Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A3E5A59
Wed, 08.05.2024
SYNBIOTIC SE
The German industrial hemp and cannabis group SYNBIOTIC SE acquires WEECO Pharma GmbH from Hildesheim/Germany. The merger makes SYNBIOTIC one of the most important players on the German and European market for medicinal cannabis.
"With WEECO Pharma, our group of companies now has a full range of high-quality cannabis flowers. Together with our othe [ … ]
Mon, 21.08.2023
SynBiotic SE
Multi-entrepreneur Frank Otto invests in SynBiotic SE:
The Munich-based company acquires majority stake in CannaCare Health and appoints Daniel Kruse as CEO
Multi-entrepreneur Frank Otto invests 3 million euros in SynBiotic SE
SynBiotic acquires majority stake in CBD retail expert Canna Care Health GmbH with its CBD network marketing subsidiary W [ … ]
Thu, 24.11.2022
SynBiotic SE
SynBiotic SE attracts Canopy Growth founder Bruce Linton as Chairman of newly created Advisory Board
Munich, 24th November 2022:
SynBiotic SE, (SBX.DE) one of Germany’s leading cannabinoid companies, accelerates implementation of the operational platform to achieve market leadership in the upcoming national legalization of recreational cann [ … ]
Thu, 24.11.2022
SynBiotic SE
SynBiotic SE attracts Canopy Growth founder Bruce Linton as Chairman of newly created Advisory Board
Munich, 24th November 2022:
SynBiotic SE, (SBX.DE) one of Germany’s leading cannabinoid companies, accelerates implementation of the operational platform to achieve market leadership in the upcoming national legalization of recreational cann [ … ]
Mon, 31.10.2022
SynBiotic SE
SynBiotic SE completes successfully capital increase and places all new shares
Munich, October 31, 2022
SynBiotic SE, as Europe's largest listed group of companies in the hemp and cannabis sector, has successfully completed the cash capital increase resolved on October 28, 2022. All 191,739 new shares were placed at the subscription price o [ … ]
Mon, 31.10.2022
SynBiotic SE
SynBiotic SE completes successfully capital increase and places all new shares
Munich, October 31, 2022
SynBiotic SE, as Europe's largest listed group of companies in the hemp and cannabis sector, has successfully completed the cash capital increase resolved on October 28, 2022. All 191,739 new shares were placed at the subscription price o [ … ]
Wed, 26.10.2022
SynBiotic SE
“Like winning the lottery”
SynBiotic SE comments on key points paper (“Eckpunktepapier”)
October 26, 2022: At today's federal press conference on the upcoming cannabis legalization, the final draft of the key points paper (“Eckpunktepapier”) of the federal government was presented. Among other points, concrete plans relating to the cu [ … ]
Wed, 26.10.2022
SynBiotic SE
“Like winning the lottery”
SynBiotic SE comments on key points paper (“Eckpunktepapier”)
October 26, 2022: At today's federal press conference on the upcoming cannabis legalization, the final draft of the key points paper (“Eckpunktepapier”) of the federal government was presented. Among other points, concrete plans relating to the cu [ … ]
Thu, 01.09.2022
SynBiotic SE
Hempamed Rx: SynBiotic SE launches full-line medical cannabis brand
Europe's largest listed corporate group in the hemp and cannabis sector supports launch with massive expansion of field sales force in the medical cannabis sector
Just in time for Expopharm: SynBiotic SE launches full-range Hempamed Rx brand (Hall B1 / Booth C58)
Wide rang [ … ]
Thu, 01.09.2022
SynBiotic SE
Hempamed Rx: SynBiotic SE launches full-line medical cannabis brand
Europe's largest listed corporate group in the hemp and cannabis sector supports launch with massive expansion of field sales force in the medical cannabis sector
Just in time for Expopharm: SynBiotic SE launches full-range Hempamed Rx brand (Hall B1 / Booth C58)
Wide rang [ … ]